Nationwide registry for needle tract seeding after endoscopic ultrasound-guided fine needle aspiration in pancreatic tumors

Nationwide registry for needle tract seeding after endoscopic ultrasound-guided fine needle aspiration in pancreatic tumors - Nationwide registry for needle tract seeding after EUS-FNA

Status

Recruiting

Phases

Unknown

Study type

Observational

Source

JPRN

Registry ID

JPRN-UMIN000052674

Enrollment

2900

Registered

2023-11-15

Start date

2023-03-01

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

pancreatic tumor

Interventions

None listed

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: 20 years of age or older Patients with pancreatic lesions that are suspicious for malignancy on various imaging examinations Patients with ECOG performance status 2 or lower Patients who need histological diagnosis by EUS-FNA to decide the follow-up or to select the treatment methods Patients who undergo transgastric EUS-FNA

Exclusion criteria

Exclusion criteria: Patients with blood vessels or other tumors in the puncture route on various imaging examinations performed prior to enrollment Patients with bleeding tendency (PT INR > 1.5 or Plt < 50000 micro L) Patients in whom antithrombotic drugs cannot be discontinued Patients in whom the tumor cannot be visualized by EUS due to a history of gastrectomy, etc. Patients with clear distant metastasis at the time of puncture or patients with pancreatic tumors which can be judged to be unresectable Patients who are deemed inappropriate as subjects by the investigator (subinvestigator)

Design outcomes

Primary

Measure	Time frame
Incidence of needle tract seeding after EUS-FNA in patients receiving surgical resection of pancreatic tumors	—

Secondary

Measure	Time frame
Incidence of needle tract seeding after EUS-FNA in patients with resected pancreatic ductal carcinomas Incidence of needle tract seeding after EUS-FNA in patients with resected pancreatic tumors other than ductal carcinomas Factors associated with incidence of needle tract seeding after EUS-FNA The time from EUS-FNA to the manifestation of needle tract seeding, size of NTS lesion, location of NTS lesion, and whether the tumor was resected or not Prognosis of patients with needle tract seeding after EUS-FNA Prognostic factors of needle tract seeding after EUS-FNA Pathological examinations of resected NTS lesions	—

Measure

Time frame

Incidence of needle tract seeding after EUS-FNA in patients with resected pancreatic ductal carcinomas Incidence of needle tract seeding after EUS-FNA in patients with resected pancreatic tumors other than ductal carcinomas Factors associated with incidence of needle tract seeding after EUS-FNA The time from EUS-FNA to the manifestation of needle tract seeding, size of NTS lesion, location of NTS lesion, and whether the tumor was resected or not Prognosis of patients with needle tract seeding after EUS-FNA Prognostic factors of needle tract seeding after EUS-FNA Pathological examinations of resected NTS lesions

—

Countries

Japan

Contacts

Public ContactReiko Ashida

Wakayama Medical University Second Department of Internal Medicine

nts@wakayama-med.ac.jp0734410627

Outcome results